Get the latest Science News and Discoveries

Concerning – The FDA Is Approving Drugs After Fewer Trials and Providing Less Information to the Public


Get the Android app

Or read this on SciTech Daily

Read more on:

Photo of information


Photo of fewer trials

fewer trials

Photo of FDA


Related news:

News photo

FDA approves the first treatment for nasopharyngeal carcinoma, a rare cancer that originates in the nasopharynx. The drug (toripalimab-tpzi) is a next-generation, programmed death receptor-1 monoclonal antibody. Because of the tumor's location (behind the nose), surgery is not usually an option.

News photo

FDA Issues Eye Drops Warning After Deadly Outbreak of Bacterial Infections

News photo

Public Invited to International Observe the Moon Night Oct. 21